ADDUCT FORMATION IN THE TOXICITY OF DITHIOCARBAMATES
二硫代氨基甲酸盐毒性中加合物的形成
基本信息
- 批准号:6164607
- 负责人:
- 金额:$ 23.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-01-01 至 2001-02-28
- 项目状态:已结题
- 来源:
- 关键词:DNA damage acylation adduct biomarker chemical stability chemical structure function crosslink disulfide bond dithiol dosage environmental toxicology hemoglobin laboratory rat neurotoxicology nuclear magnetic resonance spectroscopy radiotracer sulfides thiocarbamate toxin metabolism ultraviolet spectrometry
项目摘要
DESCRIPTION: (Adapted from the Investigator's Abstract) Human exposure to
dithiocarbamates derives from their many uses in agriculture, industry and
medicine. Although the degradative pathways of dithiocarbamates are fairly
well understood, there is presently little knowledge regarding the molecular
targets and mechanisms underlying the observed biological effects of
dithiocarbamates. One of the major decomposition products of
dithiocarbamates, CS2, is a known neurotoxicant. The principal objectives
of this project are to delineate the potential interactions of
dithiocarbamates and their decomposition products within biological systems
and to determine both the relevance of these interactions as mechanisms of
toxicity and the utility of these interactions as biomarkers of exposure and
effect. This investigation is guided by the following working hypotheses:
1) dialkyldithiocarbamates and bis(thiocarbamoyl) disulfides exert
neurotoxicity through liberation of carbon disulfide, producing
derivatization and cross-linking of proteins; and 2) that covalent
modification of proteins by carbon disulfide including dithiocarbamate
formation and covalent cross-linking can be used as biomarkers of exposure
and effect for dithiocarbamates, bis(thiocarbamoyl) disulfides and CS2.
These hypotheses will be tested through determining the morphological
changes in the nervous system and the covalent modifications produced on
peripheral marker proteins and putative target proteins within the nervous
system by bis(thiocabamoyl) disulfides; and through determination of the
dose response, sensitivity for detection and the rate of accumulation and
elimination of CS2-mediated cross-linking on hemoglobin and dithiocarbamate
formation on blood proteins following acute, subacute and chronic exposures
to environmentally relevant levels of dithiocarbamates and CS2. Delineation
of the molecular mechanisms and the development of valid biomarkers will
facilitate the performance of mechanistically based risk assessments and the
formulation of structure activity relationships for these widely used
compounds.
描述:(改编自研究者摘要)人体暴露于
二硫代氨基甲酸酯衍生自它们在农业、工业和医药中的许多用途。
药 虽然二硫代氨基甲酸酯的降解途径相当复杂,
很好地理解,目前关于分子的知识很少。
所观察到的生物效应的目标和机制
二硫代氨基甲酸盐。 其中一个主要的分解产物
二硫代氨基甲酸盐CS2是一种已知的神经毒剂。 主要目标
这个项目的目的是描述潜在的相互作用,
二硫代氨基甲酸酯及其在生物系统中的分解产物
并确定这些相互作用的相关性,
毒性和这些相互作用作为暴露的生物标志物的效用,
效果 本调查以下列工作假设为指导:
1)二烷基二硫代氨基甲酸酯和双(硫代氨基甲酰基)二硫化物
通过释放二硫化碳产生神经毒性,
蛋白质的衍生和交联;和2)共价
用二硫化碳包括二硫代氨基甲酸酯修饰蛋白质
形成和共价交联可用作暴露的生物标志物
以及对二硫代氨基甲酸酯、双(硫代氨基甲酰基)二硫化物和CS2的影响。
这些假设将通过确定形态学
神经系统的变化和产生的共价修饰
外周标记蛋白和神经内推定的靶蛋白
系统的双(硫代氨基甲酰)二硫化物;并通过测定
剂量反应、检测灵敏度和累积速率,
消除CS2介导的血红蛋白和二硫代氨基甲酸酯的交联
急性、亚急性和慢性接触后对血液蛋白的影响
二硫代氨基甲酸盐和CS2的环境相关水平。 划定
的分子机制和有效的生物标志物的发展将
促进进行基于机制的风险评估,
这些广泛使用的结构活性关系的制定
化合物.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM M VALENTINE其他文献
WILLIAM M VALENTINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM M VALENTINE', 18)}}的其他基金
Pesticide-mediated inhibition of UBA1 and cumulative risk for Parkinson's Disease
农药介导的 UBA1 抑制和帕金森病的累积风险
- 批准号:
8462271 - 财政年份:2011
- 资助金额:
$ 23.14万 - 项目类别:
Pesticide-mediated inhibition of UBA1 and cumulative risk for Parkinson's Disease
农药介导的 UBA1 抑制和帕金森病的累积风险
- 批准号:
8318607 - 财政年份:2011
- 资助金额:
$ 23.14万 - 项目类别:
Pesticide-mediated inhibition of UBA1 and cumulative risk for Parkinson's Disease
农药介导的 UBA1 抑制和帕金森病的累积风险
- 批准号:
8188050 - 财政年份:2011
- 资助金额:
$ 23.14万 - 项目类别:
OXIDATIVE STRESS IN THE CYTOTOXICITY OF DITHIOCARBAMATES
二硫代氨基甲酸盐细胞毒性中的氧化应激
- 批准号:
2596123 - 财政年份:1998
- 资助金额:
$ 23.14万 - 项目类别:
ADDUCT FORMATION IN THE TOXICITY OF DITHIOCARBAMATES
二硫代氨基甲酸盐毒性中加合物的形成
- 批准号:
6285032 - 财政年份:1994
- 资助金额:
$ 23.14万 - 项目类别:
Adduct Formation in the Toxicity of Dithiocarbamates
二硫代氨基甲酸盐毒性中的加合物形成
- 批准号:
7367974 - 财政年份:1994
- 资助金额:
$ 23.14万 - 项目类别:
相似海外基金
Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
- 批准号:
BB/Y003756/1 - 财政年份:2024
- 资助金额:
$ 23.14万 - 项目类别:
Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
- 批准号:
MR/Y503435/1 - 财政年份:2024
- 资助金额:
$ 23.14万 - 项目类别:
Research Grant
S-acylation-dependent regulation of cytokine receptor signaling and cardiac maladaptation
细胞因子受体信号传导和心脏适应不良的 S-酰化依赖性调节
- 批准号:
10561406 - 财政年份:2023
- 资助金额:
$ 23.14万 - 项目类别:
Comprehensive analysis of acidic patch binder using histone acylation catalysts
使用组蛋白酰化催化剂综合分析酸性贴片粘合剂
- 批准号:
22KJ1113 - 财政年份:2023
- 资助金额:
$ 23.14万 - 项目类别:
Grant-in-Aid for JSPS Fellows
S-Acylation of transmembrane proteins in the early secretory pathway
早期分泌途径中跨膜蛋白的 S-酰化
- 批准号:
BB/X001504/1 - 财政年份:2023
- 资助金额:
$ 23.14万 - 项目类别:
Research Grant
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
- 批准号:
10584620 - 财政年份:2022
- 资助金额:
$ 23.14万 - 项目类别:
The Molecular Mechanisms of Glycolytic Enzyme S-acylation in Neurons
神经元糖酵解酶S-酰化的分子机制
- 批准号:
576016-2022 - 财政年份:2022
- 资助金额:
$ 23.14万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
用于精准基因组编辑的抗 CRISPR 介导的酰化和生物可逆酯化
- 批准号:
10657417 - 财政年份:2022
- 资助金额:
$ 23.14万 - 项目类别:
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
YEATS2 组蛋白酰化酶抑制剂的高通量筛选
- 批准号:
10389517 - 财政年份:2022
- 资助金额:
$ 23.14万 - 项目类别:
Roles of KAT8 complexes in governing histone acylation and mouse cerebral development
KAT8复合物在控制组蛋白酰化和小鼠大脑发育中的作用
- 批准号:
RGPIN-2019-07122 - 财政年份:2022
- 资助金额:
$ 23.14万 - 项目类别:
Discovery Grants Program - Individual